loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 202167 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 DEXCEL (2)

filter

01 TABLET, EXTENDED RELEASE;ORAL (2)

filter

01 DISCN (2)

filter

01 LEVETIRACETAM (2)

filter

01 No (2)

URL Supplier Web Content
TABLET, EXTENDED R...
750MG
2015-09-04
202167
LEVETIRACETAM
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET, EXTENDED R...
500MG
2015-09-04
202167
LEVETIRACETAM
DISCN
No
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202167

Looking for FDA Orange Book APPLICATION 202167 2

19

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LEVETIRACETAM, with a corresponding application number 202167.

Regulatory Information DISCN

With a dosage strength 750MG

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2015-09-04

18

Dexcel Pharma, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LEVETIRACETAM, with a corresponding application number 202167.

Regulatory Information DISCN

With a dosage strength 500MG

Dosage Form Route TABLET, EXTENDED RELEASE; ORAL

Reference Listed Drug No

Approved since 2015-09-04

Post Enquiry
POST ENQUIRY